Publicacións nas que colabora con Enrique Navas Elorza (20)

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2009

  1. Observational study to evaluate clinical outcomes after first-line efavirenz-or Lopinavir-Ritonavir-based HAART in treatment-naive patients

    Journal of the International Association of Physicians in AIDS Care, Vol. 8, Núm. 5, pp. 308-313

2005

  1. Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults

    HIV Clinical Trials, Vol. 6, Núm. 6, pp. 312-319

  2. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804

2004

  1. High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin

    Antiviral Therapy, Vol. 9, Núm. 1, pp. 133-138

  2. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus

    Human Pathology, Vol. 35, Núm. 9, pp. 1083-1087

2003

  1. Differences in durability of treatment with initial PI-based regimens

    HIV Clinical Trials, Vol. 4, Núm. 6, pp. 391-399

  2. Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: Changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid

    Journal of NeuroVirology

2002

  1. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients

    Clinical Infectious Diseases, Vol. 34, Núm. 3, pp. 386-389

2001

  1. Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes

    AIDS, Vol. 15, Núm. 8, pp. 1068-1070

2000

  1. Effectiveness and pitfalls of initial highly active antiretroviral therapy in HIV-infected patients in routine clinical practice

    Antiviral Therapy, Vol. 5, Núm. 4, pp. 243-248

1996

  1. Central venous catheter infections in AIDS patients receiving daily home therapy for cytomegalovirus disease

    QJM - Monthly Journal of the Association of Physicians, Vol. 89, Núm. 9, pp. 695-699

1994

  1. MENINGITIS TUBERCULOSA POR MICROORGANISMOS RESISTENTES. FRACASO TERAPEUTICO EN 2 PACIENTES CON INFECCION POR HIV Y TUBERCULOSIS DISEMINADA

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 12, Núm. 3, pp. 150-153

1993

  1. NEUMONIAS EXTRAHOSPITALARIAS: ESTUDIO PROSPECTIVO DE 101 PACIENTES ADULTOS E INMUNOCOMPETENTES DURANTE UN ANO

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 11, Núm. 10, pp. 525-530

  2. ROXITROMICINA EN EL TRATAMIENTO DE LAS NEUMONIAS EXTRAHOSPITALARIAS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 11, Núm. 5, pp. 260-262

1992

  1. DESENSIBILIZACION A CLINDAMICINA EN UN PACIENTE CON SINDROME DE IMMUNODEFICIENCIA ADQUIRIDA [1]

    Medicina Clinica

1991

  1. EXANTEMA VESICULOSO HEMORRAGICO DISEMINADO Y NEUMONIA EN PACIENTE CON INFECCION POR VIH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 9, Núm. 6, pp. 373-374

  2. Neumonía por Pneumocystis carinii y neumotórax espontáneo.

    Anales de Medicina Interna

  3. VARICELA NOSOCOMIAL: ESTUDIO DE UN BROTE EPIDEMICO ENTRE PACIENTES INMUNODEPRIMIDOS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 9, Núm. 6, pp. 357-360